IMMUNE PHARMACEUTICALS INC Contracts & Agreements

Employment Agreement, dated March 7, 2019, by and between Immune Pharmaceuticals Inc. and Gary H. Rabin (Filed With SEC on March 8, 2019)

Press release dated March 7, 2019 (Filed With SEC on March 8, 2019)

First Amendment Agreement, dated as of January 15, 2019, by and between Immune Pharmaceuticals Inc. and Discover Growth Fund, LLC (Filed With SEC on January 17, 2019)

Nominee Agreement, dated March 27, 2018, by and between Cytovia International LLC and Noventia Pharma SRL (Filed With SEC on November 21, 2018)

Securities Purchase Agreement, dated October 9, 2018 (Filed With SEC on October 10, 2018)

Form of Debenture (Filed With SEC on October 10, 2018)

Form of Warrant (Filed With SEC on October 10, 2018)

Form of Investor Note (Filed With SEC on October 10, 2018)

Securities Purchase Agreement, dated September 12, 2018, by and between Immune Pharmaceuticals, Inc. and Power Up Lending Group Ltd (Filed With SEC on September 18, 2018)

Convertible Promissory Note, dated September 12, 2018, by and between Immune Pharmaceuticals, Inc. and Power Up Lending Group Ltd (Filed With SEC on September 18, 2018)

Termination Agreement, dated as of August 28, 2018, by and between Immune Pharmaceuticals Inc. and Elliot M. Maza (Filed With SEC on August 29, 2018)

General Release of Claims, dated as of August 28, 2018, by and between Immune Pharmaceuticals Inc. and Elliot M. Maza (Filed With SEC on August 29, 2018)

Supplemental Employment Agreement, dated as of August 28, 2018, by and between Immune Pharmaceuticals Inc. and Tony Fiorino (Filed With SEC on August 29, 2018)

Securities Purchase Agreement (Filed With SEC on May 14, 2018)

Form of Convertible Debenture (Filed With SEC on May 14, 2018)

Employment Agreement, dated as of November 29, 2017, by and between Immune Pharmaceuticals, Inc. and Elliot Maza (Filed With SEC on December 4, 2017)

Form of Warrant (Filed With SEC on October 18, 2017)

Form of Underwriting Agreement (Filed With SEC on October 16, 2017)

Form of Warrant (Filed With SEC on October 16, 2017)

Form of Warrant Agency Agreement (Filed With SEC on October 16, 2017)

Form of Underwriting Agreement (Filed With SEC on October 11, 2017)

Form of Warrant (Filed With SEC on October 11, 2017)

Form of Warrant Agency Agreement (Filed With SEC on October 11, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 24, 2017)

ORIGINALISSUE DISCOUNT CONVERTIBLE DEBENTURE (Filed With SEC on August 24, 2017)

Schedule A NON-DISCLOSUREAND NON-COMPETITION AGREEMENT (Filed With SEC on August 18, 2017)

LICENSE AND COMMERCIALIZATION AGREEMENT (Filed With SEC on July 12, 2017)

ASSIGNMENT AGREEMENT (Filed With SEC on July 10, 2017)

EXCHANGE AGREEMENT (Filed With SEC on July 10, 2017)

SENIORSECURED CONVERTIBLEPROMISSORY NOTE DUEJuly 7, 2018 (Filed With SEC on July 10, 2017)

June15, 2017 MEDAPHARMA SARL - and - IMMUNEPHARMACEUTICALS, INC. ASSETPURCHASE AGREEMENT ConcerningCeplene and Certain Related Assets (Filed With SEC on June 21, 2017)

STANDBY FINANCINGAGREEMENT (Filed With SEC on June 21, 2017)

IMMUNE PHARMACEUTICALS INC. (Filed With SEC on May 16, 2017)

ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE (Filed With SEC on May 15, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 10, 2017)

ORIGINALISSUE DISCOUNT CONVERTIBLE DEBENTURE (Filed With SEC on May 10, 2017)

Separation Agreement and Release of Claims (Filed With SEC on April 27, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 19, 2017)

6% CONVERTIBLE NOTE (Filed With SEC on April 19, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 19, 2017)

COMMON STOCK PURCHASE WARRANT IMMUNEPHARMACEUTICALS, INC. (Filed With SEC on April 19, 2017)

COMMON STOCKPURCHASE AGREEMENT (Filed With SEC on March 23, 2017)

COMMON STOCKPURCHASE AGREEMENT (Filed With SEC on February 3, 2017)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 22, 2016)

ImmunePharmaceuticals Inc. CONVERTIBLENOTE (Filed With SEC on November 22, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 22, 2016)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on November 22, 2016)

BINDINGAGREEMENT (Filed With SEC on September 16, 2016)

STOCK PURCHASE AGREEMENT (Filed With SEC on September 7, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 3, 2016)

COMMON STOCK PURCHASE WARRANT IMMUNEPHARMACEUTICALS inc. (Filed With SEC on August 3, 2016)

AMENDMENT NO. 1 TO LICENSE OPTION AGREEMENT (Filed With SEC on July 19, 2016)

PROMISSORY NOTE (Filed With SEC on July 19, 2016)

AMENDMENT NO. 1 TO CAPITAL ACCESSAGREEMENT (Filed With SEC on June 13, 2016)

CAPITAL ACCESS AGREEMENT (Filed With SEC on June 13, 2016)

License Option Agreement (Filed With SEC on May 16, 2016)

CAPITAL ACCESS AGREEMENT (Filed With SEC on April 20, 2016)

Schedule A (Filed With SEC on March 30, 2016)

RESEARCH AND LICENSE AGREEMENT Made in Jerusalem January 1, 2016 (the “EffectiveDate”), by and between: (Filed With SEC on January 7, 2016)

[Company Letterhead] (Filed With SEC on December 31, 2015)

IMMUNE PHARMACEUTICALS INC. 2015 EQUITY INCENTIVE PLAN (Filed With SEC on December 9, 2015)

WARRANTAGREEMENT To Purchase Shares of Common Stock of IMMUNE PHARMACEUTICALS INC. Dated as of July __, 2015 (the “EffectiveDate”) (Filed With SEC on July 29, 2015)

LOANAND SECURITY AGREEMENT (Filed With SEC on July 29, 2015)

STOCK PURCHASE AGREEMENT (Filed With SEC on July 29, 2015)

Form of Voting Agreement VOTING AGREEMENT (Filed With SEC on July 29, 2015)

COMMON STOCK PURCHASE WARRANT IMMUNEPHARMACEUTICALS INC. (Filed With SEC on July 17, 2015)

immune PharmaceuticalsInc. securitiesExchange AGREEMENT JULY 16,2015 (Filed With SEC on July 17, 2015)

AMENDMENT (Filed With SEC on July 8, 2015)

RESEARCH AND LICENSE AGREEMENT (Filed With SEC on June 29, 2015)

MEMORANDUM OF UNDERSTANDING Principles of Research and LicenseAgreement June 1, 2015 (Filed With SEC on June 11, 2015)

MEMORANDUM OF UNDERSTANDING Principles of Research and LicenseAgreement March 10, 2015 (Filed With SEC on May 15, 2015)

LEASE AGREEMENT (Filed With SEC on April 15, 2015)

Immune Pharmaceuticalsinc. 3,450,000Units Each Unit Consisting of One Share of Common Stock and One Warrant to Purchase 0.25 of a Shareof Common Stock UNDERWRITINGAGREEMENT (Filed With SEC on November 20, 2014)

FORMOF warrant To purchase ______________ shares of CommonStock of Immune Pharmaceuticals Inc. (the"Company") at a per share price and subject to theterms detailed below VOID... (Filed With SEC on November 20, 2014)

Exhibit A — Form of RestatedSeries A Warrant and Restated Series B Warrant (Filed With SEC on August 14, 2014)

AMENDMENT AGREEMENT (Filed With SEC on August 14, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 11, 2014)

COMMON STOCK PURCHASE WARRANT IMMUNE PHARMACEUTICALS INC. (Filed With SEC on March 11, 2014)

FOURTH AMENDMENT, CONSENT AND WAIVER TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 11, 2014)

THIRD AMENDMENT AND CONSENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 29, 2013)

COMMON STOCK PURCHASE WARRANT IMMUNE PHARMACEUTICALS INC. (Filed With SEC on August 29, 2013)

EpiCept Corporation 777 Old Saw Mill River Road Tarrytown, NY 10591 (Filed With SEC on August 26, 2013)

SECOND AMENDMENT AND WAIVER TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 1, 2013)

AMENDMENT NO. 4 TO MERGER AGREEMENT AND PLAN OF REORGANIZATION (Filed With SEC on June 19, 2013)

AMENDMENT NO. 3 TO MERGER AGREEMENT AND PLAN OF REORGANIZATION (Filed With SEC on March 19, 2013)

AMENDMENT TO MERGER AGREEMENT AND PLAN OF REORGANIZATION (Filed With SEC on March 5, 2013)

AMENDMENT NO. 2 TO MERGER AGREEMENT AND PLAN OF REORGANIZATION (Filed With SEC on February 12, 2013)

MERGER AGREEMENT AND PLAN OF REORGANIZATION (Filed With SEC on November 13, 2012)

[EPICEPT LETTERHEAD] September 24, 2012 (Filed With SEC on September 27, 2012)

**************** 1 (Filed With SEC on September 27, 2012)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 31, 2012)

ASSET PURCHASE AGREEMENT (Filed With SEC on June 21, 2012)

TERMINATION AGREEMENT (Filed With SEC on June 21, 2012)

CONSENT AGREEMENT (Filed With SEC on June 21, 2012)

COOPERATION AGREEMENT (Filed With SEC on June 21, 2012)

COMMON STOCK PURCHASE WARRANT EPICEPT CORPORATION (Filed With SEC on April 3, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 3, 2012)

COMMON STOCK PURCHASE WARRANT EPICEPT CORPORATION (Filed With SEC on February 9, 2012)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 9, 2012)

AMENDMENT TO SERIES B COMMON STOCK PURCHASE WARRANT EPICEPT CORPORATION (Filed With SEC on January 9, 2012)

LOAN AND SECURITY AGREEMENT (Filed With SEC on May 31, 2011)

COMMON STOCK PURCHASE WARRANT EPICEPT CORPORATION (Filed With SEC on May 31, 2011)

COMMON STOCK PURCHASE WARRANT EPICEPT CORPORATION Warrant Shares: Initial Exercise Date: September , 2011 Issue Date: March , 2011 (Filed With SEC on March 30, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 30, 2011)

COMMON STOCK PURCHASE WARRANT To Purchase __________ Shares of Common Stock of EPICEPT CORPORATION (Filed With SEC on February 11, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 11, 2011)

COMMON STOCK PURCHASE WARRANT To Purchase __________ Shares of Common Stock of EPICEPT CORPORATION (Filed With SEC on November 12, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 12, 2010)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 26, 2010)

SEVERANCE AGREEMENT (Filed With SEC on July 26, 2010)

AMENDMENT NO.1 TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 14, 2010)

SERIES A COMMON STOCK PURCHASE WARRANT To Purchase __________ Shares of Common Stock of EPICEPT CORPORATION (Filed With SEC on July 1, 2010)

SERIES B COMMON STOCK PURCHASE WARRANT To Purchase __________ Shares of Common Stock of EPICEPT CORPORATION (Filed With SEC on July 1, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 1, 2010)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on June 15, 2010)

Financial Statements (Filed With SEC on May 7, 2010)

$15,000,000 EpiCept Corporation Common Stock Equity Distribution Agreement (Filed With SEC on February 11, 2010)

SUPPLEMENTARY AGREEMENT to the Repayment Agreement of 2007-12-17/2007-12-20 (Filed With SEC on June 30, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 19, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on June 19, 2009)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on June 19, 2009)

EPICEPT CORPORATION (Filed With SEC on February 10, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 10, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on February 10, 2009)

ADDENDUM A (Filed With SEC on February 10, 2009)

EPICEPT CORPORATION (Filed With SEC on February 5, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 5, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on February 5, 2009)

EPICEPT CORPORATION (Filed With SEC on December 19, 2008)

AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on September 17, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 4, 2008)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of EPICEPT CORPORATION (Filed With SEC on August 4, 2008)

Up to 5,529,954Shares of Common Stock, par value $0.0001 per share Warrants to Purchase 2,764,978Shares of Common Stock, par value $0.0001 per share (Filed With SEC on August 4, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 23, 2008)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on June 23, 2008)

1270 Avenue of the Americas, 16th Floor, New York, NY 10020 Tel:: 212 ###-###-#### Fax:: 212 ###-###-#### www.rodmanandrenshaw.com Member: FINRA, SIPC (Filed With SEC on June 23, 2008)

PRELIMINARY PROSPECTUS SUPPLEMENT SUBJECT TO COMPLETION DATED JUNE 23, 2008(To Prospectus Dated September 18, 2007) (Filed With SEC on June 23, 2008)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 23, 2008)

COMMON STOCK WARRANT To Purchase Shares of Common Stock of EpiCept Corporation Dated as of June 23, 2008 (the Effective Date) (Filed With SEC on June 23, 2008)

EX-14.1: CODE OF ETHICS (Filed With SEC on March 18, 2008)

Re: Separation from EpiCept Corporation (Filed With SEC on February 5, 2007)

EX-10.1: LICENSE AGREEMENT (Filed With SEC on January 25, 2007)

EX-10.1: SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 9, 2006)

EX-10.2: FORM OF COMMON STOCK PURCHASE WARRANT (Filed With SEC on November 9, 2006)

EX-10.1: EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2006)

EX-4.3: FORM OF FOURTH AMENDED AND RESTATED CONVERTIBLE TERM NOTE (Filed With SEC on November 1, 2005)

EX-4.5: FORM OF FOURTH AMENDED AND RESTATED PREFERRED STOCK PURCHASE WARRANT (Filed With SEC on November 1, 2005)

EX-4.7: AMENDMENT TO SERIES C WARRANT (Filed With SEC on November 1, 2005)

EX-4.9: AMENDMENT TO ALPINVEST SERIES B WARRANT (Filed With SEC on November 1, 2005)

EX-4.11: AMENDMENT TO TVM SERIES B WARRANT (Filed With SEC on November 1, 2005)

EX-10.3: 2005 EQUITY INCENTIVE PLAN (Filed With SEC on November 1, 2005)

EX-10.4: 2005 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on November 1, 2005)

EX-10.18: AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (Filed With SEC on November 1, 2005)

EX-10.19: AMENDED AND RESTATED 8% SENIOR NOTE (Filed With SEC on November 1, 2005)

EX-10.20: AMENDED AND RESTATED 8% SENIOR NOTE (Filed With SEC on November 1, 2005)

EX-10.21: 8% SENIOR NOTE (Filed With SEC on November 1, 2005)

EX-10.22: 8% SENIOR NOTE (Filed With SEC on November 1, 2005)

EX-10.24: AMENDED AND RESTATED STOCK PURCHASE WARRANT (Filed With SEC on November 1, 2005)

EX-10.25: AMENDED AND RESTATED STOCK PURCHASE WARRANT (Filed With SEC on November 1, 2005)

EX-10.28: AMENDMENT TO SECOND EXCHANGE OPTION AGREEMENT (Filed With SEC on November 1, 2005)

EX-10.19: FORM OF WARRANT ISSUED PURSUANT TO THE NOTE PURCHASE AGREEMENT (Filed With SEC on April 18, 2005)

EX-10.20: FORM OF NOTE ISSUED PURSUANT TO THE NOTE PURCHASE AGREEMENT (Filed With SEC on April 18, 2005)

COOPERATION AGREEMENT (Filed With SEC on March 30, 2005)

INVESTMENT AGREEMENT (Filed With SEC on March 30, 2005)

LETTER AGREEMENT (Filed With SEC on March 30, 2005)

EX-10.18: NOTE PURCHASE AGREEMENT (Filed With SEC on March 30, 2005)

EX-10.21: SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 30, 2005)

Category

Industry

Companies

Contracts

IMMUNE PHARMACEUTICALS INC Contracts & Agreements